Fidelity Investments’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.9K Buy
6,967
+2,649
+61% +$18.2K ﹤0.01% 3930
2025
Q1
$12.4K Sell
4,318
-86,147
-95% -$248K ﹤0.01% 4420
2024
Q4
$425K Sell
90,465
-1,633,550
-95% -$7.68M ﹤0.01% 2991
2024
Q3
$6.15M Sell
1,724,015
-3,605,931
-68% -$12.9M ﹤0.01% 2070
2024
Q2
$33M Sell
5,329,946
-34,719
-0.6% -$215K ﹤0.01% 1477
2024
Q1
$50.6M Sell
5,364,665
-319,950
-6% -$3.02M ﹤0.01% 1322
2023
Q4
$38.4M Sell
5,684,615
-290,801
-5% -$1.96M ﹤0.01% 1391
2023
Q3
$26.5M Buy
5,975,416
+421,676
+8% +$1.87M ﹤0.01% 1477
2023
Q2
$18.3M Sell
5,553,740
-602,588
-10% -$1.99M ﹤0.01% 1678
2023
Q1
$17.5M Buy
6,156,328
+922,603
+18% +$2.63M ﹤0.01% 1668
2022
Q4
$38.1M Sell
5,233,725
-2,571,917
-33% -$18.7M ﹤0.01% 1361
2022
Q3
$63.1M Buy
7,805,642
+1,678,411
+27% +$13.6M 0.01% 1150
2022
Q2
$30M Buy
6,127,231
+30,753
+0.5% +$151K ﹤0.01% 1481
2022
Q1
$144M Buy
6,096,478
+14,161
+0.2% +$335K 0.01% 915
2021
Q4
$108M Buy
6,082,317
+37,554
+0.6% +$664K 0.01% 1071
2021
Q3
$171M Buy
6,044,763
+3,665,282
+154% +$103M 0.01% 870
2021
Q2
$24.9M Sell
2,379,481
-36,250
-2% -$380K ﹤0.01% 1748
2021
Q1
$28.5M Buy
2,415,731
+665,995
+38% +$7.85M ﹤0.01% 1636
2020
Q4
$20.5M Sell
1,749,736
-86,500
-5% -$1.01M ﹤0.01% 1707
2020
Q3
$14.6M Sell
1,836,236
-14,316
-0.8% -$114K ﹤0.01% 1701
2020
Q2
$33.8M Buy
1,850,552
+68,101
+4% +$1.25M ﹤0.01% 1323
2020
Q1
$21.3M Buy
1,782,451
+81,700
+5% +$975K ﹤0.01% 1376
2019
Q4
$27.7M Buy
1,700,751
+207,867
+14% +$3.39M ﹤0.01% 1472
2019
Q3
$9.44M Buy
+1,492,884
New +$9.44M ﹤0.01% 1854